SBIR/STTR Reauthorization : Navigating the Changes

The SBIR/STTR landscape is evolving, with recent reauthorization efforts introducing meaningful shifts in how startups access and compete for non-dilutive funding. These updates include stricter disclosure requirements around foreign affiliations, enhanced due diligence, and a stronger emphasis on commercialization outcomes and real-world impact, all of which directly influence how applications are reviewed and evaluated. At the same time, agencies are increasing focus on compliance, transparency, and clear pathways from research to market, raising expectations for how applicants position both their innovation and long-term business viability. Join us for a focused, practical session breaking down what these changes mean for your funding strategy. We’ll cover how new requirements, such as foreign affiliation disclosures, heightened due diligence, and commercialization expectations, are reshaping the SBIR/STTR application landscape. What you’ll learn Key updates from the latest SBIR/STTR reauthorization How new requirements (e.g., foreign risk disclosures, security compliance) impact your application Strategies to remain competitive under stricter review standards Common pitfalls founders are now facing, and how to avoid them How to position your startup for success in this new funding environment Featured Speaker Dr. Nao Gamo (Founder & CEO, Grant & Proposal Atelier) With over 20 years of experience spanning neuroscience research, MedTech entrepreneurship, and federal grant strategy, Dr. Gamo has secured funding from both sides, as a founder and as a reviewer. She now helps startups, researchers, and clinicians successfully navigate the SBIR/STTR landscape and unlock non-dilutive capital. Hosted by Amplify MedTech - an initiative to build a cohesive MedTech ecosystem by fostering collaboration, networking, and resource sharing among startups, investors, service providers, entrepreneurial service organizations (ESOs), economic development agencies, entrepreneurs, and inventors. We aim to create a thriving, sustainable, and locally connected MedTech community that will drive economic growth in the region.